SEC complaint filed against Natera over promotion of prenatal screening technology
January 14, 2022 at 18:12 PM EST
A complaint to the SEC alleges that Natera misled investors and others about its prenatal screening product.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|